Clay Thorp's Net Worth

Clay Thorp's net worth is estimated to be at least $49,492,895.11 as of 11/23/2024. CoreStreet's estimation of Clay Thorp's net worth is based on their sale of stock and current holding of stock.

Clay Thorp is Director at Clearside Biomedical Inc. They have executed at least 38 trades of stock as per SEC Form 4 filings. Their most recent trade was for 10,000 units of CLSD stock on 09/25/2023. Their biggest sale was on 05/30/2018 when they sold 800,000 units of G1 Therapeutics Inc stock for $38,400,000.00. They typically trade 4 times per year.

Total value of insider buys:
  • $2,176,048.52
Total value of insider sells:
  • $47,316,846.59
Most recent insider trade:
  • Sept. 25, 2023

Clay Thorp's Insider Trading History

Clearside Biomedical IncTitleAmountPriceTypeTotal Value
Sept. 25, 2023
Director10,000$0.86Buy$8,600.00
Dec. 21, 2022
Director14,000$1.02Buy$14,280.00
Feb. 10, 2021
Director32,873$4.43Sell$145,627.39
Dec. 6, 2018
Director8,000$1.36Buy$10,880.00
May 18, 2018
Director161,139$13.08Sell$2,107,698.12
Dec. 7, 2017
Director5,000$6.13Sell$30,650.00
Dec. 5, 2017
Director15,000$6.37Sell$95,550.00
Nov. 16, 2017
Director35,000$7.00Sell$245,000.00
Nov. 14, 2017
Director15,000$7.02Sell$105,300.00
Oct. 5, 2017
Director35,000$8.57Sell$299,950.00
Sept. 15, 2017
Director24,500$7.52Sell$184,240.00
Sept. 14, 2017
Director6,000$7.52Sell$45,120.00
Sept. 13, 2017
Director8,500$7.49Sell$63,665.00
Aug. 9, 2017
Director24,500$7.57Sell$185,465.00
Aug. 8, 2017
Director5,000$7.98Sell$39,900.00
Aug. 7, 2017
Director4,500$8.02Sell$36,090.00
May 19, 2017
Director24,000$8.36Sell$200,640.00
May 17, 2017
Director44,485$8.63Sell$383,905.55
May 16, 2017
Director9,544$8.61Sell$82,173.84
May 15, 2017
Director15,941$8.94Sell$142,512.54
April 19, 2017
Director68,485$7.46Sell$510,898.10
April 18, 2017
Director44,455$7.48Sell$332,523.40
April 17, 2017
Director22,000$7.43Sell$163,460.00
March 16, 2017
Director68,485$6.56Sell$449,261.60
Feb. 22, 2017
Director27,000$7.55Sell$203,850.00
Feb. 17, 2017
Director41,485$7.60Sell$315,286.00
Jan. 20, 2017
Director68,485$8.53Sell$584,177.05
June 7, 2016
Director138$7.00Sell$966.00
Vigil Neuroscience IncTitleAmountPriceTypeTotal Value
May 16, 2022
Director21,802$2.76Buy$60,173.52
March 28, 2022
Director3,000$7.20Buy$21,600.00
PhaseBio Pharmaceuticals IncTitleAmountPriceTypeTotal Value
Aug. 18, 2021
Director10,000$3.00Buy$30,000.00
Nov. 24, 2020
Director5,000$3.60Buy$18,000.00
July 1, 2019
Director2,908$14.00Sell$40,712.00
June 18, 2019
Director400$14.00Sell$5,600.00
Dec. 4, 2018
Director4,000$3.13Buy$12,520.00
G1 Therapeutics IncTitleAmountPriceTypeTotal Value
May 30, 2018
Major Shareholder800,000$48.00Sell$38,400,000.00
May 23, 2018
Major Shareholder37,500$51.11Sell$1,916,625.00
May 22, 2017
Major Shareholder133,333$15.00Buy$1,999,995.00